News & Publications
Healthcare de Jure host Matthew Fisher speaks with BioDot CEO Tony Lemmo about diagnostic testing
![](https://cdn.prod.website-files.com/601e02f4ddfcc67ffc193a4a/6462b819cf5cb1781edd5d1b_biodot-news.webp)
![](https://cdn.prod.website-files.com/601e02f4ddfcc67ffc193a4a/6462b819cf5cb1781edd5d1b_biodot-news.webp)
This week, Healthcare de Jure host Matthew Fisher speaks with BioDot CEO Tony Lemmo about diagnostic testing. Tune in to learn about the distinctions between rapid and lab-based testing, the expedited growth of testing through #COVID19, and the innovation occurring in the testing space.
![Healthcare de Jure host Matthew Fisher speaks with BioDot CEO Tony Lemmo about diagnostic testing](https://cdn.prod.website-files.com/601e02f461a5202d87a6c35c/6079e50724e8ea74097f297f_healthcare.webp)
![Healthcare de Jure host Matthew Fisher speaks with BioDot CEO Tony Lemmo about diagnostic testing](https://cdn.prod.website-files.com/601e02f461a5202d87a6c35c/6079e50724e8ea74097f297f_healthcare.webp)
Related Products
No items found.
No items found.